A reactivation of VZV and an outbreak of Shingles can be bad enough without having to worry about the possibility of heart disease or stroke. That’s why we recommend helping the immune system target the latent Varicella Zoster Virus. – Mike Evans, polyDNA
Rochester, NY (PRWEB) January 23, 2014
Herpes Zoster (HZ) has been linked to both heart disease and stroke. Herpes Zoster, a condition caused by the Varicella Zoster Virus (VZV), increases the risk of transient ischemic attacks (brain dysfunction caused by a loss of blood flow), for stroke, and for myocardial infarctions (heart attacks) (1). polyDNA recommends that people infected with VZV consider taking Gene-Eden-VIR. This natural product was clinically proven to reduce symptoms of viral infections in a study that followed FDA guidelines.
Study authors discovered that the VZV virus increases the risk of stroke, transient ischemic attack, and heart attack dramatically. “Risk factors for vascular disease were significantly increased in cases of HZ compared with controls… (and)…TIA and MI were increased in cases whose HZ occurred when they were younger than 40 years (1).”
According to study authors, the bottom line is that “…conditions that predispose to vascular disease…are significantly more common in subjects with HZ (1).”
“Shingles is caused by the varicella zoster virus, the same virus that causes chickenpox. After a person recovers from chickenpox, the virus stays in the body in a dormant (inactive) (latent) state. For reasons that are not fully known, the virus can reactivate years later, causing shingles.” (See the CDC’s website last updated on January 10, 2011) (2).
“A reactivation of VZV and an outbreak of Shingles can be bad enough without having to worry about the possibility of heart disease or stroke. That’s why we recommend helping the immune system target the latent Varicella Zoster Virus.” – Mike Evans, polyDNA
polyDNA recommends targeting the latent VZV with Gene-Eden-VIR, a natural antiviral proven to be safe and effective in a clinical study that followed FDA guidelines. In a post marketing clinical study published on August 12, 2013 in the medical journal Pharmacology & Pharmacy in a special edition on Advances in Antiviral Drugs, researchers showed that Gene-Eden-VIR is safe and effective (3). Additionally, up to 70% of those studied reported a decrease in viral symptoms, and users experienced an increase in overall health (3).
Each ingredient of Gene-Eden-VIR was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target latent viruses (3).
To learn more about Gene-Eden-VIR and herpes, visit: http://gene-eden-kill-virus.com/Herpes-Remedy.php. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
(1) Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK. Published on January 8, 2014.
(2) CDC - Shingles (Herpes Zoster). Last Updated January 10, 2011.
(3) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing
Clinical Study. Published on August 12, 2013.
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Gene-Eden-VIR , an antiviral natural remedy that helps the immune system kill latent viruses.